Robert Figlin, MD and Melissa Johnson, MD, Discuss Highlights from the 19th World Lung Conference

Friday October 5, 2018

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center speaks with Melissa Johnson, MD, Associate Director, Lung Cancer Research, Sarah Cannon Research Institute about targeted therapy, prevention, I-O in NSCLC, and I-O in SCLC.

Robert Figlin, MD, and Paul Bunn, MD, Discuss Highlights from the 19th World Lung Conference

Wednesday October 3, 2018

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center speaks with Paul Bunn, MD, Distinguished Professor, Division of Medical Oncology, University of Colorado about prevention, I-O in NSCLC, and I-O in SCLC.

Featured Videos

Sai-Hong Ignatius Ou, MD, PhD, regarding combo chemotherapy & immunotherapy in 1st line NSCLC

Benjamin Philip Levy, MD, regarding combo chemotherapy & immunotherapy in 2nd line NSCLC

Benjamin Philip Levy, MD, on options for NSCLC patients who progress on 1st line I-O & chemotherapy